Publication | Open Access

Association of Exon 19 and 21 EGFR Mutation Patterns with Treatment Outcome after First-Line Tyrosine Kinase Inhibitor in Metastatic Non–Small-Cell Lung Cancer

Treatment OutcomeMedicineEgfr Mutation PatternsPathologyCancer GenomicsCancer TreatmentCancer GeneticsOncologyRadiation OncologyLung CancerMolecular OncologyExon 19